Paper4128550
Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase.
Chabner BA and 2 others. Biochem Pharmacol, 1973. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase. Papers, record 4128550. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4128550
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminohydrolases | Major topic |
| Azacitidine | Major topic |
| Leukemia, Myeloid | Major topic |
| Blood Proteins | |
| Carbon Radioisotopes | |
| Chromatography, Ion Exchange | |
| Cytarabine | |
| Cytidine | |
| Deamination | |
| Humans | |
| In Vitro Techniques | |
| Kinetics | |
| Leukocytes | |
| Spectrophotometry, Ultraviolet |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599195 | A Nanoparticle-Based Strategy to Stabilize 5-Azacytidine and Preserve DNA Demethylation Activity in Human Cardiac Fibroblasts. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41599195 | PubMed |
| 41124688 | Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine Deaminase. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/41124688 | PubMed |
| 38482976 | In Situ Formation of Fibronectin-Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38482976 | PubMed |
| 36435726 | Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee. | J Geriatr Oncol | 2023 | https://conductscience.org/library/papers/36435726 | PubMed |
| 34959720 | Azacitidine Omega-3 Self-Assemblies: Synthesis, Characterization, and Potent Applications for Myelodysplastic Syndromes. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34959720 | PubMed |
| 34019616 | Cytidine deaminase can deaminate fused pyrimidine ribonucleosides. | Org Biomol Chem | 2021 | https://conductscience.org/library/papers/34019616 | PubMed |
| 33792103 | Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia. | Oncologist | 2021 | https://conductscience.org/library/papers/33792103 | PubMed |
| 32394351 | Zebularine-induced myeloma cell death is accompanied by decreased c-Myc expression. | Cell Oncol (Dordr) | 2020 | https://conductscience.org/library/papers/32394351 | PubMed |
| 31020568 | Clinical update on hypomethylating agents. | Int J Hematol | 2019 | https://conductscience.org/library/papers/31020568 | PubMed |
| 29927979 | A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent. | PLoS One | 2018 | https://conductscience.org/library/papers/29927979 | PubMed |
| 29774579 | Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma. | Hepatology | 2018 | https://conductscience.org/library/papers/29774579 | PubMed |
| 29706891 | Targeting DNA Methyltranferases in Urological Tumors. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29706891 | PubMed |
| 29019016 | Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections. | Eur J Clin Microbiol Infect Dis | 2018 | https://conductscience.org/library/papers/29019016 | PubMed |
| 27960273 | Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. | Chem Rev | 2016 | https://conductscience.org/library/papers/27960273 | PubMed |
| 27713340 | Demethylating Agents in the Treatment of Cancer. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713340 | PubMed |
| 27330573 | A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. | Clin Epigenetics | 2016 | https://conductscience.org/library/papers/27330573 | PubMed |
| 26190889 | SGI-110: DNA Methyltransferase Inhibitor Oncolytic. | Drugs Future | 2013 | https://conductscience.org/library/papers/26190889 | PubMed |
| 26174363 | A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine. | Biomed Chromatogr | 2016 | https://conductscience.org/library/papers/26174363 | PubMed |
| 24457556 | AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine. | Oncotarget | 2014 | https://conductscience.org/library/papers/24457556 | PubMed |
| 24225777 | Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress. | Sci Rep | 2013 | https://conductscience.org/library/papers/24225777 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CDA | 978 | PubTator's text mining | https://conductscience.org/library/genes/978 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4128550
GET https://conductscience.org/api/papers/v1/4128550/cited_by?page=2